Epigenetics provides a means of understanding how environmental factors might alter heritable changes in gene expression without changing DNA sequence, and hence the origin, of some diseases that are not explained by conventional genetic mechanisms. Various animal models have been described, most notably the agouti viable yellow (A vy ) and axin 1 fused (Axin1 Fu ) mice, which lend themselves particularly well to studying this link between epigenetics and development abnormalities, because particular changes in DNA methylation patterns can be linked to a broad spectrum of heritable pathologies in the mice. In addition, there are specific examples, both in mice and other animal species, where nonmutagenic, environmental insults to either parent, such as those caused by consumption of endocrine-disrupting chemicals, can cause unexpected transgenerational phenotypic changes in offspring. Animals derived by somatic cell nuclear transfer also frequently exhibit pathologies that can be linked to inappropriate nuclear reprogramming during early embryo development and provide another means to study a link between epigenetics and disease. This review will consider how all of these animal models might help elucidate the epigenetic basis for a wide range of phenotypes.
INTRODUCTION
When the term epigenetics was originally introduced by Waddington [1] , it referred to any causal mechanisms that act on genes to govern a resulting phenotype. This definition was refined by Holliday [2] to implicate DNA methylation changes that result in altered gene expression but later broadened to explain how the expression of a gene might be changed and then stably maintained by any modification that does not mutate the nucleotide sequence of the gene itself [3] [4] [5] [6] .
However, even this more expansive definition has needed further refinement as the term epigenetics began to be employed to include any manner of change that caused alterations in gene expression. A more restricted definition of epigenetics is a mitotically or meiotically heritable change in gene expression that occurs independently of an alteration in DNA sequence [7] . The primary difference between the broader and narrower definitions is that the former does not imply that the change is heritable from cell to cell, or even transgenerational. The latter definition implies that the change in gene expression extends beyond the cell in which the original response occurred, can be transmitted to other somatic cells, and can even be passed onto other generations through the germ cells. In this review, any meiotically or mitotically heritable changes in DNA methylation, histone modification, and chromatin organization in general, are regarded as epigenetic modifications and part of the ''epigenome.'' The goal of this review, however, is not to discuss all aspects of these phenomena, but instead to define a series of animal models where propensity to disease can be linked to epigenetics.
The field of environmental epigenetics (i.e., epigenetic changes modulated by an environmental cause) has rapidly mushroomed in this decade, with animal models, particularly rodents, providing a valuable resource in this field. In particular, environmentally induced epigenetic changes can be mediated through diet [8] [9] [10] [11] [12] [13] [14] , toxicants [15] [16] [17] [18] [19] [20] and, in the case of in vitro fertilization (IVF)-produced offspring, through components in the embryo culture media [21] [22] [23] [24] [25] . This review details some of the animal models that have been employed to understand how these epigenetic changes underpin diverse physiological phenomena. Particularly for maternal nutritionbased epigenetic studies, rodents and other animal models have proved to be the most useful because they reach sexual maturity early (6-8 wk) , are generally polytocous (litterbearing), and exhibit similar placentation to humans (hemochorial), but they demonstrate an abbreviated gestational period (18-21 days) . Thus, several generations can be analyzed within a relatively short timeframe (1-2 yr), which is essential for transgenerational studies. In contrast, similar studies would be impractical in humans because they would be considered unethical and time restrictive. Additionally, to date, there is a not single locus and corresponding phenotype in humans that have been identified to be sensitive to diet. In contrast, a number of select markers have been identified in animals, in particular agouti viable yellow (A vy ) and axin 1 fused (Axin1 Fu ) mice, which are further discussed below. These mice have a well-characterized locus whose methylation pattern governs dramatic phenotypic outcomes. From this standpoint, these mice are a valuable animal model for studying how maternal diet can alter epigenetic and accompanying phenotypic responses in her offspring. However, neither of these genes is present in the human genome, and thus the changes identified in these mice might not translate to humans. Additionally, the A vy and Axin1 Fu mice routinely used for epigenetic studies are in the inbred C57BL/6J line [8-10, 13, 14] , and thus these mice are presumably genetically identical. In contrast, humans are markedly diverse, with genetic and epigenetic variability, which is evident even in monozygotic human twins [26, 27] . Even with these caveats, these mouse strains are considered valuable animal models in this field becauase they have high throughput, a distinct visual marker (coat color with the A vy mice and tail morphology in the Axin1 Fu mice), specific methylation changes that correspond to phenotypic changes, a well-understood underpinning mechanism and, in the case of the A vy mice, they are prone to diseases (diabetes, obesity, and cancer) of human health concern. These mice, as well as some of the animal models to be discussed, confirm that maternal or adult diet can alter the methylation pattern and phenotype of the animal.
Animals, including outbred strains, derived by somatic cell nuclear transfer (SCNT) also frequently exhibit pathologies that can be linked to inappropriate nuclear reprogramming during early embryo development and provide another means to study a link between epigenetics and disease. If such changes can occur in animals, then similar results are likely in humans. As with rodent models, epigenetics most likely governs a range of diseases in humans. However, the complex nature of most diseases in humans precludes identification of an epigenetic change in a single locus leading to a given disease. Global epigenetic approaches, including DNA methylation microarray studies, might permit such individual loci to be identified in the future. Currently, however, animal models are an optimal resource to demonstrate a cause and epigenetic effect between alteration of various environmental components, change in DNA methylation, and disease risk. Tables 1-3 [8, 10-15, 19, 28-50] provide a summary of the animal models and studies that have examined the impact of environmentally induced epigenetic changes on phenotypic outcomes. Based on these animal models, inferences might be made in humans whether methyl supplements are of benefit in the maternal and adult diet to offset various diseases, including cancer.
METHYL DONORS AND COFACTORS
To date, the majority of studies on animal models employed to study the relationship between nutrition, epigenetics, and disease have examined DNA methylation changes. Other epigenetic changes, such as histone modifications, chromatin structural patterns, and gene expression changes controlled by RNAi, although central to the topic of epigenetics, have not so far been studied widely in the context of diet and its influence on disease. Accordingly, this review is focused primarily on DNA methylation and not on other kinds of chromatin modifications.
DNA methylation is governed by a variety of dietary factors, including folate, vitamin B 2 (riboflavin), vitamin B 12 (cobalamin), vitamin B 6 (pyridoxine), methionine, choline, and alcohol, that mediate one-carbon metabolism and thereby increase the amount of available S-adenosylmethionine [51] . In one-carbon metabolism, serine or glycine transfers a carbon unit to tetrahydrofolate, leading to the formation of 5,10-methyl-enterahydrofolate. Besides donating a methyl group to convert uracil to thymidine, 5,10-methylenterahydrofolate can also be reduced to 5-methyltetrahydrofolate by methylenetetrahydrofolate reductase (MTHFR). The 5-methyltetrahydrofolate has the ability to methylate homocysteine, resulting in methionine synthesis. Patients who are deficient in MTHFR because of a germ line mutation have pathological accumulation of homocysteine and associated mental retardation and vascular diseases [52] [53] [54] . Even single-nucleotide polymor- [8, 10, 14] .
Examination of the effects of maternal diet on offspring phenotype and disease risk.
May not be applicable to humans.
Axin-fused (Axin1 Fu ) mice Maternal methyl supplemented diet induced methylation of the IAP site within the Axin1 Fu gene and increased number of offspring displaying straight versus kinked tails [13] .
Examination of the effects of maternal diet on offspring phenotype.
Wild-type C57BL/6J
Maternal methyl supplemented diet resulted in methylation within Runx3, increases the risk for allergic airway disease in offspring [28] .
Various pathologies in offspring as a result of diet supplementation.
Unclear whether similar outcomes would occur in outbred mice (and by analogy, humans).
Rats
Maternal methyl supplements altered offspring behavior possibly retarding learning responses [29] , while another study suggested enhancement of memory performance [30] .
Alterations in complex neuroendocrine and behavioral responses in offspring.
Neither study examined the methylation patterns to determine if a single or multiple genes are responsible Sheep
Restriction of methyl supplements in the diet of pregnant ewes altered DNA methylation patterns, elevated blood pressure, increased obesity, and insulin resistance in offspring [31] .
phisms (SNPs) in MTHFR, in particular C667T SNP, that alter its thermolability and activity are associated with an increased risk for a variety of cancers in humans, including those originating from the uterus, breast, ovary, esophagus, stomach, and colon [55] [56] [57] [58] . In these patients, dietary folate intervention might be used to decrease the cancer in risk in these individuals [59] . DNA methylation requires the synthesis of S-adenosylmethionine (SAM). Methionine adenosyltransferase converts methionine into SAM in an ATP-dependent process [60] . Sadenosylmethionine serves as the primary donor to add methyl groups onto a wide range of acceptors, including DNA, RNA, and histone proteins. The end result of this reaction is the production of S-adenosylhomocysteine (SAH) as a byproduct of the reaction (Fig. 1) . Importantly, SAH can competitively bind and inhibit the catalytic activity of DNA methyl transferases (DNMTs) [61] , which are the enzymes responsible for maintaining and initiating methylated cytosines within DNA. In this capacity, SAH suppression of DNMT might act as a homeostatic mechanism to prevent aberrant DNA methylation. S-adenosylhomocysteine can be hydrolyzed to homocysteine and converted back to methionine in a reaction catalyzed by homocysteine methyltransferase, which uses methylcobalamin, derived from vitamin B 12 , and zinc. Betaine and choline, which are considered lipotropes based on their ability to prevent fatty liver [62] , can also serve as sources of methyl groups because they each possess three methyl groups that can be transferred to SAM (Figure 1 ) [63] .
REPROGRAMMING OF METHYLATION PATTERNS
DNA methylation is one of the major epigenetic means to govern gene expression and corresponding phenotypic outcomes. Cytosines within CpG islands are the predominant nucleotides methylated in mammalian DNA, with approxi- [11, 12, [33] [34] [35] [36] [37] [38] .
One of the best characterized animal models for adult methyl diet deficiencies.
C57BL/6J mice Mice on a methyl-deficient diet exhibited altered Igf2 expression [39] . Another study suggests that a methyl-deficient diet resulted in reversible increased expression of Igf2 and H19 [40] .
Link the expression pattern of imprinted genes and methyl deficient diets.
Did not address the mechanisms leading to the changes in imprinted gene expression. Not clear if epigenetic changes are linked to pathologies. Apc/Msh2 mice Mice on a folate-deficient diet were protected against developing intestinal carcinogenesis, which they are otherwise predisposed to develop [41] .
Deficiencies of dietary methyl components might epigenetically alleviate and trump genetics to prevent disease.
It is not certain if the observed effects are epigenetic in origin, and may not be applicable to humans.
BALB/c mice A chronic folate-deficient diet in these mice resulted in DNA methylation changes and intestinal tumors [42] .
Folate diet deficiency results in contrasting effects depending on the species studied.
C57BL/6J and DBA/2J Both strains of mice subjected to a methyl-deficient diet developed hepatic steatitis that is due to DNA methylation and histone changes [43] .
Demonstrates that methyldeficient diet results in several epigenetic changes that alter disease risk.
May not be applicable to humans. Yellow coat color females were more likely to birth offspring with a yellow coat color that were more likely to become obese and diabetic with age than brown coat color females. No transgenerational paternal effects, though, are observed in these mice [44] .
F2

Axin1
Fu mice Both the paternal and maternal germline resulted in transgenerational effects with parents possessing kinked tails more likely to generate offspring with this defect than parents with normal tail morphology [45] .
F1
Rats
In utero exposure to a protein-restricted diet resulted in changes in methylation of Pppara and Nr3c1 in male offspring, which is also observed in the F2 males [46] .
F2
Rats In utero and transgenerational exposure to vinclozolin decreased male fecundity [15] . F4 Rats Transgenerational effects from exposure to vinclozolin results in these males are selectively shunned by females [47] .
F3
Rats Transgenerational effects of the vinclozolin exposure resulted in females with uterine and renal pathologies and increased cancer risk [48] .
Mice Transgenerational exposure to DES increased reproductive cancers in females, including those originating from the ovary, uterus, and mammary gland [19, 49] . Transgenerational exposure of males to DES resulted in increased incidence of sperm granulomas and reproductive cancers of the prostate and testis [50] .
F2
ANIMAL MODELS TO STUDY EPIGENETICS mately 3% of these methylated in human DNA [64] . DNA methylation patterns change during two main events of murine development: in primordial germ cells (approximately Embryonic Days 11.5-12.5) and in preimplantation embryos. At the time of fertilization, the two gametes fuse to produce a totipotent zygote [65] . To achieve this totipotency, erasure of the DNA methylation patterns must occur and the histone proteins modified [66] . Although the maternal genome is not altered at the time of fertilization, the paternal genome undergoes dramatic changes, including exchanging protamines for histones and accompanying histone modification and rapid DNA demethylation [66] . This selective demethylation of the paternal genome is considered active demethylation because it is not dependent on DNA replication [64] . Although the causal mechanisms governing this demethylation of the paternal genome are not fully understood, factors within the sperm nucleus and cytoplasmic maturity of the oocyte seem to be required. Some regions, including imprinted genes, heterochromatin surrounding centromeres, and some repetitive elements, of the paternal genome escape demethylation [64] . Almost all of the DNA methylation patterns will be erased as preimplantational embryo development proceeds [65, 66] . However, retroviral particles embedded within the host genome remain methylated during embryogenesis. In contrast to the active DNA demethylation process that occurs in the paternal genome, the maternal genome is passively demethylated. This passive demethylation during preimplantational embryonic development might originate by preventing DNMT1, which is the enzyme normally responsible for maintenance of DNA methylation, from functioning at the replication fork and methylating the newly synthesized genomic DNA [65] . However, the methylation stamp on imprinted genes is maintained during this early embryonic period [65] . As the preimplantational embryo differentiates into cells that will comprise the inner cell mass (ICM), which will give rise to the conceptus proper, and those that will form the trophectoderm (TE), which differentiate into the majority of the placenta, de novo DNA methylation occurs [64] . As further discussed below, DNMT3A and 3B predominantly mediate de novo DNA methylation, which selectively hypermethylates the ICM cells. In contrast, the TE cells continue to be hypomethylated [64] . Thus, embryonic development is characterized by a wave of demethylation followed by reestablishment of similar and novel methylation patterns in the developing embryo [67] , which might permit the removal of acquired epigenetic modifications, particularly those that occur during the development of the gametes.
As the primordial germ cells (PGCs) differentiate from the ICM cells, they are hypermethylated [64] . In the process of migrating to the genital ridge, the PGCs rapidly abort their genome-wide methylation stamp. As in the case of postfertilization spermatozoa, this demethylation of the migratory PGC is presumed to be an active process [64] . As the methylation patterns are erased, the parent-of-origin methylation marks are reestablished in the appropriate genes. Once this process occurs, gametogenesis is halted, with female gametes remaining in meiotic prophase and male gametes in mitosis. As the oocytes and spermatozoa develop, the maternal and paternal imprints, respectively, are conferred within the genome. Differentiating spermatozoa also exhibit hypermethylation of nonimprinted sequences.
DNA methylation is maintained and initiated by DNMT. DNMT1 is seemingly responsible for the maintenance of DNA methylation (e.g., of daughter chromatids after mitosis), whereas de novo DNA methylation is a result of DNMT3A and DNMT3B [68] . These enzymes catalytically remove the methyl group from SAM and place it on the 5-carbon of cytosines in CpG islands. DNMT targets hemimethylated CpG islands that are produced during DNA replication. The DNA polymerase clamp, proliferative cell nuclear antigen, interacts and directs DNMT1 to replication foci [69] . Recently, another factor, ubiquitinlike containing PHD and RING finger domains 1 (UHRF1; also termed NP95 and ICBP90), has been identified to tether DNMT1 to methylated DNA [65] . In general, methylated DNA is considered silenced or inactive. The methyl groups must be removed before transcription can occur.
As mentioned above, this demethylation of DNA might occur through active and passive processes. A third potential means by which DNA demethylation might occur is through indirect active process or mismatch/excision repair. In this section, we will consider the active and indirect active processes that govern DNA demethylation.
Active demethylation presumably requires a specific demethylase enzyme. Many have proposed that the methylCpG-binding domain 2 (MBD2) protein serves this function [70] , although there is not uniform consensus on this role [69] . The MBD2 protein might instead associate with or act as a chaperone for the other components of the demethylase machinery [69] . In support of this role, mice that lack MBD2 have reduced incidence of tumors that are attributed to hypermethylation of select genes, such as cyclin-dependent kinase inhibitor 2A (Cdkn2a; also termed p16, Ink4a), integrin alpha 4 (Itga4), and tissue inhibitor of metalloproteinase 3 (Timp3) [71] . Other potential candidate demethylase enzymes are methyl-CpG-binding protein 4 (MBD4) and a T/G mismatch repair glycosylase, 5-methylcytosine DNA glycosylase that cleaves the bond between the sugar and cytosine base [72] . The DNA repair mechanisms replace this cleaved base with a nonmethylated cytosine, with the net effect of demethylation. This process is thus 476 considered indirect active process of demethylation or mismatch/excision repair of the methylated cytosines [72] . This process might account for active removal of select methylated cytosines. However, nucleotide excision repair of methylated cytosines expends an enormous toll in terms of genetic machinery required and risk for genetic mutations, and thus this process is unlikely to account for genome-wide loss of methylation patterns, as occurs in postfertilization spermatozoa and PGC.
Recently, tet oncogene 1 (TET1) has been implicated as another potential enzyme that might initiate demethylation by converting 5-methylcytosine to 5-hydroxymethylcytosine (hmC) [73] . The resulting hmC might result in passive demethylation by preventing DNMT1 from binding and methylating the nascent DNA strand. Active demethylation might also occur in response to this conversion to hmC. One possibility is that this compound acts as an intermediate, and under the proper conditions is converted to cytosine [73] . As with the mismatch/excision repair detailed above, hmC might incite various DNA glycosylases, including thymine DNA glycosylase and MBD4, to cleave this compound with DNA repair mechanisms replacing the cleaved hmC compound with a nonmethylated cytosine [73] . . Correct orientation of the ventral specific promoter results in completely yellow coat color region in the ventrum. In the dorsum region, expression originates from the hair cycle-specific promoter, which results in agouti (brown) patterned hair in the dorsum. b) A. In this allelic form, there is an inversion of the region containing the ventral-specific promoter (exon 1A) and pseudoexon 1A that results in a loss of ventral agouti expression except for that arising from the hair cycle-specific promoter. As a result, the agouti gene is confined in its expression during the hair cycle growth to the mid phase of the hair cycle, with a resulting brown coat color in both the ventrum and dorsum regions. c) A vy . In this allelic form, a retrotransposon, or IAP, has inserted into pseudoexon 1A of the A allele. This naturally occurring viral insertion results in agouti expression being driven from a cryptic promoter in the LTR of the IAP. Although endogenous transcription factors cannot suppress the viral promoter within the IAP site, its expression is governed by methylation of cytosines within this sequence. When the LTR is fully demethylated, ubiquitous agouti expression in all organs occurs and yellow obese syndrome result. However, if this promoter site is fully or partially methylated, the mice have brown to in-between coat color patterns, respectively. These latter forms will remain healthy compared with those displaying a yellow coat color. d) The hair follicle and melanin pigment of an agouti coat color hair follicle is displayed here to demonstrate the differences in melanin pigment that are laid down during the hair follicle cycle. The hair follicles of yellow coat color mice contain exclusively pheomelanin. Black coat color mice (a/a), in contrast, only contain eumelanin throughout the hair follicle. Modified from Figure 1 in Chen et al. [79] , with permission from the Genetics Society of America.
ANIMAL MODELS TO STUDY EPIGENETICS
EPIGENETIC INFLUENCE OF MATERNAL DIET ON OFFSPRING'S RISK FOR DISEASE
Viable Yellow Mice
The best characterized of all animal models in which an epigenetic change in a gene is inherited and leads to welldefined pathological outcomes is the A vy mouse. The coat color of these mice is governed by the expression of the agouti gene [74] . The agouti coat color of wild-type (WT) mice results from a band of yellow pigmentation (pheomelanin) in the middle of the hair follicle, which is otherwise darkly pigmented (eumelanin; Fig. 2 ).
In mice, the agouti-related protein (AGRP; also know, as agouti signaling protein [ASIP] ) is a 131-amino acid hormone that is not secreted into the circulation but exerts its effects in a paracrine manner [75] . The human ortholog (ASIP) of the agouti protein is 132 amino acids and is 87% identical in sequence to the murine protein [76] . The major difference between the WT mouse agouti protein and the human ortholog is the site of expression [77] . In humans, ASIP is expressed in several organs and tissues, including the foreskin, testis, ovary, kidney, liver, and adipose tissue [74, 76, 77] , whereas in the mouse, it is hair follicle specific [74] .
Within mice, various forms of the agouti gene have been identified. The nonagouti (a) allele is a loss-of-function mutation so that the mice lack the subapical yellow band and are black [78] . In WT mice, transcription of the agouti gene is initiated from a promoter within exon 2 of the agouti (A) allele (Fig. 2) [74] . This promoter is only active in the skin, and even then exclusively during the mid stage of hair growth when the subapical yellow band is laid down [79] . Mice with the A W locus have differential expression of the agouti gene in the ventrum versus dorsum regions (Fig. 2a) . This difference arises because of anatomical variation in the promoter used to transcribe this gene. In the ventrum region, a ventral-specific promoter results in expression of agouti throughout the hair follicle cycle and a corresponding yellow coat color. In contrast, agouti expression in the dorsum region is driven by the hair follicle-specific promoter, which confines agouti expression to the mid phase of the hair cycle and leads to a brown coat color (Fig. 2a) . In mice with the agouti (A) allele, a 15-kb region that contains exon 1A and pseudoexon 1A, PS1A (a 4.1-kb interrupted, inverted duplication) has undergone inversion, leading to expression that is initiated solely from a hair cycle-specific promoter in exon 2, which leads to the agouti coat color in the dorsum and ventrum regions (Fig. 2b ) [79] .
Although ] ) exist, the two most well-characterized agouti mutations in mice are the A vy and A y forms, with the former being the most commonly employed for epigenetic-based studies. For illustration, we shall consider just these two examples. The A vy ''viable yellow'' mutation was first described in the 1960s [80] . The A Y allele is homozygous lethal and arises from a deletion that disrupts the expression of the agouti and adjacent heterogenous nuclear ribonucleoprotein (hnRNP) associated with lethal yellow (Raly) gene that encodes a novel RNAbinding protein [81, 82] . The early lethality and lack of a distinct epigenetic marker limit the usefulness of A Y mice for epigenetic-based studies. In contrast, mice with the A vy allele have an intracisternal A particle (IAP) inserted in the PS1A region (Fig. 2c) [74] . As a result, agouti expression comes under control of a promoter in the long terminal repeat (LTR) of the IAP proximal to the agouti gene, whose ability to drive expression is correlated with the degree of IAP methylation. Hence, A vy mice have coat colors ranging from yellow (hypomethylation of the A vy IAP) to mottled (yellow with varying degrees of agouti patches) to completely pseudoagouti (full hypermethylation of the A vy IAP). Expression of agouti in organs other than the skin results in ''yellow obese syndrome,'' which is typified by obesity, hyperinsulinemia, hyperglycemia, and increased predilection for cancer in some strains of mice [78] . As mentioned previously, mice with the A iapy and A iy forms also have an IAP within the agouti locus [83] , but negligible other information is available on these mice.
Agouti is primarily an antagonist of the melanocortin receptors (MCRs) [84, 85] . In the WT mouse, only MC1R expressed by hair follicles is antagonized by agouti, whereas a second receptor, MC4R, which occurs predominantly in the hypothalamus, is unaffected unless the agouti gene product is expressed ectopically [86] . Deletion of MC4R results in obese mice that are black [86] . Mice with the yellow obese syndrome, as manifested in the dominant agouti mutant alleles, exhibit ubiquitous expression of the agouti gene in all organs [84] . Additionally, these mice display yellow coat colors because the agouti gene product inhibits MC1R in the hair follicle throughout the hair cycle, and they are obese because the protein antagonizes MC4R in the hypothalamus [87] . Recently, it has been shown through microarray analysis that treatment of a stable melanocyte cell line, termed melan-a melanocytes, with recombinant murine agouti protein results in pleiotropic effects that extend beyond antagonism of the MCR [88] . These other effects include suppression of melanogenic proteins and upregulation of genes governing morphogenesis, particularly of the nervous system, cell adhesion, and extracellular matrixreceptor interactions. It remains to be determined whether similar gene responses occur in A vy mice. Most intriguingly, the addition of nutrients likely to enrich the pool of methyl donors and vitamin cofactors required for methylation to the diet of mothers increases methylation of the IAP promoter site, such that more offspring are pseudoagouti and less prone to the yellow-obese syndrome [8, 14, 89] . Curiously, supplementing maternal diet with the soy product genistein also promotes IAP methylation [10] , although it is unclear whether this outcome is because genistein acts as a phytoestrogen, a tyrosine kinase inhibitor, or in some other capacity. Together, these experiments have made viable yellow mice a powerful model to study the relationship between epigenetics, maternal diet, the so-called metabolic syndrome, and disease prevention.
In certain genetic backgrounds, yellow coat color A vy mice are more strongly predisposed to various cancers than brown or black coat color mice [90] [91] [92] [93] (reviewed in Wolff et al. [78, 85] ). These cancers can originate from diverse organs, including the liver, lung, breast, urinary bladder, and skin [93] [94] [95] . One study reported that A vy mice in a C3H background develop hyperplastic mammary alveolar nodules by 16 wk of age, followed by severe mammary cancer [93] . Viable yellow mice on a C57Bl/6J background are more resistant to cancer than other strains but display extensive hyperplasia of the urinary bladder, lung, and b-cells of the pancreas [78, 96] . My laboratory has demonstrated that viable yellow mice on this background have marked hyperplasia of the reproductive tract tissues, such as the uterus (Fig. 3) . These findings might explain the reduced fertility observed in these mice. Yellow A vy mice in the cancer-resistant BALB/c background fed by oral gavage 6.0 mg daily of dimethylbenz(a)anthracene develop breast cancer at a higher rate than brown coat color A vy mice in the same genetic background 478 ROSENFELD [97] . These results confirm that the systemic expression of agouti gene in yellow coat color A vy mice increases the likelihood that their cells will become cancerous. This increased susceptibility to neoplastic transformation possibly occurs because proliferating cells are more susceptible to mutagenesis.
Hyperinsulinemia in yellow A vy /a mice in the BALB/c 3 VY background was initially blamed for predisposing tissues of these mice to increased cellular proliferation and neoplasia [85] (reviewed in Wolff et al. [78] ). However, pseudoagouti A vy /a mice, which have normal insulin concentrations, develop lindane-induced tumors at equal frequency as their yellow counterparts with hyperinsulinemia. Even in the culture dish, fibroblasts derived from newborn A vy /a mice transform and proliferate more readily than cells derived from a/a murine counterparts [90] .
To date, the A vy mouse is the only animal model where a variety of maternal supplements, including methyl donors and cofactors, genistein, and bisphenol A [8] [9] [10] 14] , epigenetically alter the offspring's coat color and risk for diseases, including diabetes, obesity, and cancer in certain genetic backgrounds. Their coat color provides a distinct visual marker that can be assessed during postnatal development to determine their later predilection for these above diseases. However, it has not been determined whether adult exposure to these dietary supplements can reduce the risk for disease in these mice, which is germane in the case of human cancer. Controlled studies with these supplements should be tested in A vy mice to determine whether they can alter their later risk for disease. The propensity of these mice to develop cancer affords them an optimal animal model to test whether dietary supplements can alleviate cancer progression through epigenetic mechanisms, and these results might have applicability to humans. One limitation of such cancer studies in A vy mice is that these epigenetic changes occur through alterations of the methylation pattern of the A vy allele, and no comparable agouti gene with a retroviral insert is present in humans. Second, almost all current epigenetic studies employ A vy mice in an inbred line, such as C57BL/6J, and thus, presumably, these mice are genetically identical. Hence, these studies might not fully mirror the responses that would occur in genetically diverse human populations. Even with these caveats, however, the viable yellow mice are a valuable animal model for environmental epigenetic studies, and as such, are one of the best characterized epigenetic animal models to date.
Axin1-Fused (Axin1
Fu
) Mice
The Axin1
Fu allele was first identified in 1937 [98] , but the reason that mice with this allele demonstrated marked phenotypic variation eluded classic geneticists for decades. We now recognize that these phenotypic variations are governed by epigenetic rather than genetic changes [99] .
Axin1
Fu is a multifunctional protein that regulates the winglesstype mouse mammary tumor virus integration site family (WNT), transforming growth factor-beta (TGFB), mitogenactivated protein kinase (MAPK) signaling pathways, and the transformation-related protein 53 (TRP53) activation cascade [100] . These pathways, in turn, govern a diverse range of embryological development processes and, in adulthood, tumorigenesis. As in A vy mice, Axin1 Fu mice have an IAP element that governs gene expression. In the Axin1
Fu allele, the IAP is embedded within the intron 6 region of this gene [101, 102] . This retroviral particle results in various alternative transcripts of the Axin1
Fu gene, including the full-length 3.9-kb transcript and transcripts that terminate after exon 6, potentially because of a premature stop codon caused by the aberrant splicing between exons 6 and 7. Additionally, a cryptic internal promoter within the inserted IAP may give rise to transcripts entirely from the C-terminal portion [101, 102] . These mice correspondingly demonstrate a range of odd tail development, with the most severely affected mice exhibiting markedly kinked tails. These kinks in the tail are attributed to axial duplications during embryogenesis [103] . Confounding this already complex situation, some mice with the Axin1
Fu gene, however, have normal tail development. The recent discovery that a methyl-supplemented diet fed to the mother during her pregnancy induces methylation of the Axin1
Fu in her fetuses at midgestation and ultimately reduces the incidence of kinked tails in her pups [13] further attests to the power of dietary supplements to alter the predilection for various postgestational pathologies [104] . These results further explain why Axin1 Fu mice demonstrated a range of tail morphology. Those with severely kinked tails have complete demethylation of the IAP site within this locus [13] . In contrast, the IAP site within this same allele is fully methylated in those mice with straight tails [13] 
Other Examples of How Maternal Diet Alters the Risk for Disease and Phenotype of WT Offspring
If the results obtained with the mouse strains discussed above are correct, it can be reasonably assumed that a broad range of other, unspecified loci, some in the control regions of genes, will become hypermethylated because of consumption of excess amounts of methyl supplements in an otherwise balanced diet. It must also be anticipated that some of these ''marks'' will be transmitted to the offspring of a pregnant mother. Further, there is no reason to suppose that analogous outcomes would not occur in other species, including humans, and some of the resulting phenotypes might prove detrimental. In mice, such a potentially ''bad'' consequence of a methylsupplemented diet provided during pregnancy to C57BL/6J female mice is an increase in the risk of allergic airway disease in offspring [28] . A proposed target gene is the runt-related transcription factor 3 (Runx3). This gene seemingly confers protection against airway disease, and methyl supplements in the maternal diet appear to result in hypermethylation of the Runx3 promoter site and downregulation of its expression in the exposed progeny. To test whether the in utero-induced methylation patterns are reversible, the investigators isolated splenocytes from the exposed offspring and treated them in vitro with the demethylating agent 5-azacytidine, a treatment that led to the reexpression of Runx3 mRNA, as well as nuclear factor of activated T cells, cytosolic component 1 (Nfatc1) and Janus kinase 2 (Jak2). These collective results imply that although the in utero environment can influence the methylation patterns of DNA in the offspring, plasticity exists in these patterns, even after birth.
A second example has been noted in rats. Here, methyl supplementation to a pregnant dam's diet in the form of added betaine and choline results in offspring with retarded learning responses, as assessed in the Morris swimming test, and sons that exhibited increased anxiety [29] . The former test examines spatial memory by placing the animals into a circular pool divided into quadrants containing a platform concealed below the water surface and measures how long and how much distance an animal travels before it reaches the platform. Others have obtained contrasting results in rats, however; specifically, that maternal diets supplemented with choline increase memory performance of offspring and delay the memory decline normally associated with age [30] . Neither of these studies, however, measured methylation patterns, and thus it is not certain whether these phenotypic outcomes are due to methylation or other types of epigenetic changes within the offspring. These studies, however, are useful in that the results demonstrate a causative effect between in utero methyl supplementation and neuroendocrine responses of the offspring. Further work in this field is needed to determine whether these behavioral responses are governed by methylation changes in a single locus or several loci.
The effects of restricted amounts of dietary vitamin B 6 , vitamin B 12 , folate, and methionine have been tested in pregnant Scottish Blackface ewes [31] . Offspring born to these ewes exhibit higher blood pressure and are more obese and insulin resistant than controls. Additionally, the offspring born to ewes on the methyl-restricted diet demonstrate marked differences in methylation patterns compared with normal sheep when liver DNA is examined. The vast majority (88% of 4% of 1400 CpG islands) of the genes examined with a restriction landmark genome scanning approach are demethylated in those exposed to the restricted diet compared with those born to control ewes. The remaining loci are hypermethylated in the restricted offspring. This change in the epigenome brought on by maternal diet might potentiate disease development in the restricted offspring.
Maternal diet might induce epigenetic changes other than DNA methylation, including alteration of histone protein structure and chromatin organization. Feeding a very high-fat diet to pregnant female Japanese macaques results in global hyperacetylation of the H3 histone protein and decreased expression of histone deacetylase 1 (HDAC1) in offspring [32] . As a consequence of the diet and possibly the change in histone structure, the livers of the offspring exhibit increased expression of glutamic pyruvate transaminase (alanine aminotransferase) 2 (Gpt2), DnaJ subfamily A member 2 (Dnaja2), and retinol dehydrogenase 12 (Rdh12) compared with the livers from control fetuses, although the clinical significance of these gene expression changes is uncertain [32] .
In honeybees (Apis mellifera), the behavioral and reproductive status (i.e., whether the individual is destined to be a sterile worker or fertile queen) may be governed by DNA methylation. Worker and queen bees have identical DNA sequences, but during larval development, the nurse bees feed a contrasting diet to those fated to become queens versus those that will become workers. Larvae destined to be queens are fed a royal jelly, a presently uncharacterized mixture of nutrients, whereas those to become workers are fed a less esoteric diet. Whatever the basis of the phenomenon, these early nutritional inputs are hypothesized to alter the expression of DNMT3, because this enzyme controls de novo DNA methylation, and result in a dramatic difference in the reproductive status of newly hatched larvae [105] . Thus, changes in nutritionally driven epigenetic cues can be used to switch a bee's status from a sterile worker to a fertile queen [105] .
MANIPULATION OF POSTWEANING TO ADULT DIET TO UNDERSTAND HOW EPIGENETICS MEDIATES ADULT-ONSET DISEASES
Because we cannot control what our parents and grandparents consumed, the germane question is whether the diet from child to adulthood can readjust the methylation patterns and reduce the risk for adult-onset diseases, such as cancer. Several animal studies have been performed to address this question.
Banting and Best documented one of the earliest protective effects of a methyl dietary component, choline (reviewed in Newberne [106] ). Pancreatectomized dogs subjected to insulin treatment did not develop hepatic lipidosis (fatty liver) when they were fed lecithin, which contains a choline moiety. As mentioned above, choline is considered a lipotrope for its ability to protect against hepatic lipidosis [62] . In contrast, rats fed a methyl-deficient diet exhibit lower concentrations of SAM, overall DNA hypomethylation, and elevated expression of protooncogenes, such as myelocytomatosis oncogene (Myc), FBJ osteosarcoma oncogene (Fos), and Harvey rat sarcoma virus oncogene 1 (Hras1) within 1 wk of being on this diet [12] . The long-term results of feeding this methyl-deficient diet to rats include fatty livers and hepatic carcinogenesis [12] . Thus, the initial results that Banting and Best obtained with choline supplementation are most likely attributed to an increase in SAM production and subsequent methylation and silencing of genes, whose expression would otherwise predispose to liver pathology.
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Postweaning diet can alter the kidney expression of imprinted genes, such as insulin-like growth factor 2 (Igf2) in mice [107] . Hybrid C57 mice that are placed on a methyl donor-deficient postweaning diet that lacks folic acid, vitamin B 12 , methionine, and choline exhibit inappropriate expression of maternal Igf2 and concomitant decrease from the normally expressed paternal allele. The overall net effect is that this methyl-deficient diet reduces expression of Igf2 in the exposed animals compared with those weaned onto a natural control diet. However, another study reveals that C57BL/6 mice on a choline-and methionine-deficient diet exhibit an increase in expression of the imprinted genes, Igf2 and H19 fetal liver mRNA (H19), but these changes are reversible when shorter-term choline-and methionine-deficient dietary periods are employed [40] . These collective studies reveal that expression of imprinted genes exhibits malleability, even after birth, and subtle changes in diet can alter their expression. The conflicting results between the two studies might be attributed to the fact that the former experiment employed a diet deficient in more methyl supplements than the latter, and second, the duration and timing of the diets might have influenced the results.
The time when the postweaning diets are fed relative to disease onset can cause variation in the course of disease. Adenomatous polyposis coli (Apc)/mutS homolog 2 (Msh2) mice are genetically prone to intestinal carcinogenesis. However, by placing them on a folate-deficient diet at 3 wk of age, they are protected against later cancer development. The alleviative effects of low folate are blunted if the pups are not placed on the diets until 6 wk of age [41] . Thus, a narrow window of time exists for these diets to provide protection. Rats on a folate-deficient diet from weaning through puberty paradoxically have increased genomic DNA methylation in the liver compared with control rats, and these methylation changes persist into adulthood, even when the rats are placed on a control diet [108] . These folate-deficient rats might exhibit an increase in genomic DNA methylation due to diet-induced increased expression of the DNMT or other overcompensatory mechanisms that remain to be elucidated. This latter study, however, suggests that some postweaning diet-induced DNA methylation patterns are not reversible.
The strain of mice employed for such dietary studies can govern their predilection for cancer. BALB/c mice that are exposed for 1 yr to a folate-deficient diet develop intestinal tumors and concurrent methylation changes more rapidly than controls. However, these pathological responses to reduced dietary folate are absent in C57BL/6 mice fed the same diet [42] . Different animal species also display contrasting responses to methyl-deficient diets. Although a methionineand choline-deficient diet lowers 5-methyl cytosine concentrations and enhances liver tumor formation in F344 male rats (as further described below), such responses are not observed in exposed C3H mice [109] . However, male inbred C57BL/6J and DBA/2J mice that are placed on a lipogenic methyldeficient diet (for 6, 12, and 18 wk), which induces a liver condition similar to human nonalcoholic steatohepatitis, develop hepatic steatosis and several epigenetic abnormalities [43] . These epigenetic changes include loss of cytosine methylation in genomic and repetitive elements in major and minor satellites and corresponding increased expression of genes located in these regions, histone modifications, and decreased expression of DNMT1 in C57BL/6J and DBA/2J mice and marked elevation of DNMT3A in C57BL/6J mice [43] . These combined studies suggest that the strain of rodents might render them more sensitive to methyl dietary deficiencies.
Although decreased dietary folate concentrations can suppress some cancers in rodents, including N-methyl-Nnitrosurea-induced mammary cancer [110] , most animals and humans on methyl-deficient diets have an increased risk for certain cancers, including colon, breast, and hepatic tumors [63, 104, [111] [112] [113] [114] [115] . One possible explanation for this increased threat is that the methyl deficiency leads to hypomethylation of oncogenes, permitting their promiscuous expression. Additionally, hypomethylation of retroviruslike sequences, including IAP, may disrupt the expression of genes within their locus of influence [63, 116] . Rats fed hypomethylated diets exhibit increased hepatic expression of protooncogenes, such as Myc, Fos, and Hras1, within several days, and this pattern positively correlates with the duration of the diet [11, 12, 33] . Replenishment of methyl donors in the diet results in remethylation of several cytosines in CpG islands of hepatic DNA [33] . Addition of methyl donors to the diet may reverse the early stages of liver carcinogenesis in rats [117] . However, some of the methylation changes induced by the methyldeficient diets fed to weaned offspring can persist for up to 14 mo in rats [118] .
A diet that is deficient in key methyl donors, including choline and methionine, is known to lead to hepatic carcinogenesis in F344 male rats [34, 35, 37] . In contrast, female rats appear to be more resistant to hepatic cancer induced by such diets [119] . In males, the same dietary regimen results in upregulation of DNMTs 1 and 3 [120, 121] , increase in methyl-CpG-binding domain proteins, including MBD2 [120, 122] , alteration of acetylation and methylation patterns for various histone proteins [123] , and overall decrease in the percentage of 5-methyldeoxycytidine in hepatic DNA [34] . These epigenetic changes are accompanied by an overall increase in DNA synthesis and cell proliferation [124] . It is intriguing to consider whether similar epigenetic and genetic changes occur in females which, as indicated above, are less likely to develop full-blown hepatic cancer in response to a methyl-depleted diet. Although some of the methylation changes in these male rats on the methyl-deficient diets are reversible, many of the methylation changes and accompanying carcinogenetic effects may be permanent, even when the rats are placed on a complete diet [33] . A recent study in Fisher 344 rats suggests that feeding a methyl-deficient diet for 9 wk results in DNA damage and aberrant DNA methylation [36] . If the rats are maintained on this diet for 18 wk and then provided a methyl-sufficient diet, the DNA lesions can be repaired. However, the DNA methylation changes persist, and the methyl-sufficient diet fails to rescue the animals from developing liver carcinogenesis [36, 37] .
These collective studies suggest that rodents on hypomethylated diets are at an increased risk for certain cancers compared with those that are fed a control diet with adequate methyl components. Importantly, some of the epigenetic and pathological changes can be reversed once they are placed on a diet containing these methyl donor compounds, whereas other changes are irreversible. Epigenetic changes, including DNA methylation, seem to provide a better indicator for risk of hepatic cancer than genetic changes that can be reversed when the rats are placed on a methyl-sufficient diet. It remains to be determined whether similar outcomes are encountered in humans on methyl-deficient diets. If so, dietary therapeutic strategies might be designed to intervene in the early stages of cancer development. However, these studies in rodents might also serve as a warning that the diet we consume as children might plague us as adults.
ANIMAL MODELS TO STUDY EPIGENETICS
TRANSGENERATIONAL EPIGENETIC EFFECTS
Jean-Baptiste Lamarck has become famous as a result of his theory regarding the inheritance of acquired characteristics, which suggests that individuals can pass on certain features that they acquired during their lifetime to their offspring [125] . Some of the examples he chose, including the gradual lengthening of the neck of the giraffe as a result of its foraging lifestyle, fell into disfavor, first as a result of Darwin's theory of natural selection and later by the implications of Mendelian inheritance and the notion of the gene. However, inheritance of acquired characteristics has gradually acquired new currency. Thus, there are several examples of transgenerational inheritance of phenotype, including the A vy mouse discussed previously, that elude conventional genetic inheritance patterns and can probably be explained on the basis of inherited epigenetic modifications of the genome. As stressed previously, such inheritance patterns do not involve a change in DNA sequence but survive meiosis and can be passed through the maternal or paternal germ lines. One hypothesis to account for why transgenerational effects have evolved, particularly in plants, is the idea that the transfer of epigenetic information across generations might confer ''memory'' of environmental stresses experienced in earlier generations, thereby preserving a rapid response to this stressor in subsequent generations [126] . This explanation for the existence of transgenerational effects might hold true for animals as well.
Effective transgenerational studies generally require animal species that reach sexual maturity at an early age, exhibit a short gestational period, and are litter bearing. Otherwise, statistically valid experiments cannot be readily performed in a reasonable timeframe. For these reasons, almost all of the transgenerational studies to date have been performed with rodents, including inbred and outbred strains of mouse.
Transgenerational effects have been documented in the A vy mouse model. Yellow coat color females are significantly more likely to birth yellow coat color offspring than genetically identical mice with agouti markings, and these effects persist into the F(2) generation. Thus, even grand-offspring bear a similar phenotype, in this case coat color to their grandmother [44] . Importantly, no paternal germ line effects on coat color have been observed in these mice [44] . In other words, the epigenetic mark is preserved through the oocyte but not through the sperm. On the other hand, supplementation of the initiating females with methyl supplements does not confer protective effects on coat color and disease into the F(2) and F(3) generations [127] . Great-grandchildren are not protected by what their grandmother ate. This observation is particularly puzzling because it suggests that the increased methylation imposed on the locus of the F(1) generation pups by the founding mother's diet is not subsequently maintained, whereas existing hypermethylation on a dark-coated founder is more stable and transmitted across generations. As discussed earlier, A vy mice are also prone to obesity, and this obesity phenotype, like coat color, is transmitted through the female germ line. Obese viable yellow females tend to produce more obese offspring than their leaner counterparts. However, early exposure of these obese, founder dams to a methyl-supplemented diet reduces the obesity in their offspring and tends to lead to darker coats, suggesting that maternal diet in this case can offset the transgenerational effects [128] .
In contrast to A vy mice, both the paternal and maternal germ lines are capable of transmitting the Axin1
Fu gene to the next generation. In this example, both males and females with kinked tails produce more offspring with the defect than parents that have normal tail morphology [99] .
Protein restriction during gestation can likewise result in transgenerational methylation changes in some candidate genes [46] . In utero exposure of rats to a protein-restricted diet, for example, results in altered methylation of the peroxisome proliferator-activated receptor alpha (Ppara) and nuclear receptor subfamily 3, group C, member 1 (Nr3c1), formerly termed glucocorticoid receptor (Grl1), promoter site in F(1) male offspring, a change that can be transmitted to the F(2) generation. Further work needs to be done, however, to determine the phenotypic ramifications of these methylation changes in the F(1) and F(2) males.
Exposure to a range of toxicants, including vinclozolin [47, 48] , diethylstilbestrol (DES) [19, 49, 50] , methoxychlor [15] , and chromium [129] , can result in transgenerational disease states, including testis defects, prostate disease, kidney disease, reproductive and breast cancer development, and immune abnormalities, which in many cases are due to epigenetic alterations within the male germ line, but the transgenerational effects of DES [49] and vinclozolin [48] can also be passed through the female germ line. In utero exposure to methoxychlor, like vinclozolin, results in decreased male fecundity in rats, as exemplified by a dearth of spermatogenic cells in the treated animal, a phenotype that persists into the subsequent two generations [15] . Another example of transgenerational effects of an environmental pollutant is associated with chromium toxicity. Exposure of NIH Swiss male mice to Cr(III) chloride 2 wk before mating results in hypomethylation of the 45S ribosomal RNA (45SrRNA) gene (and presumably other genes as well) in their sperm. The offspring of these exposed males are heavier and have increased serum concentrations of thyroxine. They also exhibit the upregulation of many thyroxine-responsive genes, including some oncogenes, such as protein tyrosine phosphatase 4a2 (Ptp4a2), Kruppellike factor 5 (Klf5), and IKAROS family zinc finger (Ikzf1), also called zinc finger protein subfamily 1A, 1 (Zfpn1a1) [129] . It remains to be determined whether these offspring indeed develop cancer more frequently than nonexposed counterparts.
Transgenerational exposure to an endocrine disruptor, such as vinclozolin, can govern female mate preference. Females selectively shun male mice whose progenitors, even three generations removed, have been exposed to vinclozolin [47] . This preferential mate selection demonstrates that besides exerting transgenerational effects, these endocrine-disrupting toxicants might have transpopulational consequences and ultimate failure of some populations to reproduce at expected rates.
Endocrine disruptors, such as vinclozolin, additionally exert effects through the female germ line. Pregnant females extending from the F(1) to F(3) generations who are derived from vinclozolin-exposed P1 females tend to exhibit uterine hemorrhage and anemia during the latter half of pregnancy. This phenomenon is not observed in any of the control females [48] . Kidney abnormalities and increased risk for cancer are likewise selectively observed in the F(2) and F(3) generations of the vinclozolin-derived females.
The synthetic estrogen DES provides another example of an endocrine-disrupting chemical that has recently been demonstrated to have transgenerational effects. From 1938 to 1971, nearly 5 million pregnant women were administered DES, usually with the goal of preventing spontaneous abortion. Although the rationale for this treatment is now regarded as dubious, almost 10 million mothers, daughters, and sons were directly exposed to this estrogenic compound [130] . However, DES is not a ''pure'' estrogen, and retrospective studies have clearly shown that its administration led to a range of 482 reproductive development abnormalities, as well as to cancers of the reproductive tract. Clear cell carcinoma of the vagina and breast cancer, and testicular cancers, cryptorchidism, and decreased sperm counts in males, are just a few of the observed pathological effects [130, 131] . In 1971, the Food and Drug Administration finally reversed its prior approval and banned DES usage in pregnant women [130] . The transgenerational effects of DES, although perhaps less clear cut than with vinclozolin, have been demonstrated in F(1) and F(2) murine descendents of dams exposed in utero to DES. These progeny display a higher incidence in cancers of the reproductive system, including those originating from the ovary, uterus, cervix, and mammary glands [49] . A second study has demonstrated that descendents of DES-exposed dams exhibit an increased incidence of uterine adenocarcinoma compared with non-DES descendents [50] . Male mice descendents are also at greater risk for sperm granulomas and inflammation within the epididymis, proliferative lesions of the rete testis, and increased incidence of tumors of the entire reproductive tract system, including ones originating from the rete testis, Leydig cells, seminiferous epithelium, and prostate gland [50] . The paternal germ cell line can also transmit the transgenerational effects of DES, as evidenced by mating of male mice exposed in utero to DES to control females, where female offspring of such matings exhibit an increased incidence in uterine sarcomas, ovarian tumors, and lymphomas [50] .
PARAMUTATIONAL CHANGES
Paramutational changes were initially described in plants, but examples have since been documented in animals, especially in mice [132] [133] [134] [135] [136] . Paramutations are heritable changes in gene expression due to interaction between alleles, with one allele or labile element acting as the ''paramutagen,'' which provokes the change and dominates the expression states, and the other as the ''paramutable'' allele, which is generally suppressed and subject to the epigenetic change by the former. Because paramutations are another example of an epigenetic change, I shall consider them in this review. Most paramutable changes that have been described in involve gene silencing due to siRNA [137] . One example of an RNAinduced paramutation that has been described in mice is the kit oncogene (Kit) locus [138] . This gene encodes a tyrosine kinase receptor that regulates the synthesis of melanin, germ cell differentiation, and hematopoiesis. Although homozygous Kit mutant mice die shortly after birth, heterozygous Kit mice are viable. However, these heterozygous mice have white tail tips and feet. Notably, when the heterozygous Kit mice are crossed to WT mice, some of the WT progeny, Kit*, have white tail tips and feet and reduced Kit mRNA levels, which seemingly contradicts normal Mendelian inheritance. When these WT Kit* mice are bred to normal WT mice without the white markings, their progeny continue to demonstrate the white tail and feet. This paramutable change is attributed to RNA molecules in the gametes that control the stability of WT Kit transcripts by targeting them for degradation, thereby suppressing Kit expression in the offspring. It is intriguing to consider whether other paramutational changes exists that are influenced by environmental factors.
EPIGENETICS AND CLONED ANIMALS
Although human cloning is viewed with almost universal repugnancy, cloning of diverse animal species has largely been accepted. At the same time, cloning has provided unexpected insights into how phenotype can be influenced by subtle failures in reprogramming, including degree of DNA methylation. Cloned animals are derived from a single genome. Adult somatic DNA, which has a considerably different methylation patterns than haploid germ cell DNA, contributes to the zygote. Initially, it was uncertain whether the methylation patterns of the resulting cloned offspring would mirror the uniparental DNA. However, it is now clear that even though cloned animals have the same DNA sequence as the donor somatic cell, their epigenetic patterns and resulting phenotype can be markedly different from their ''parent,'' almost certainly because epigenetic patterns are reprogrammed during early embryonic development [139] . These differences underscore the influence that environment can exert on the epigenome and how these effects might emerge as differences in gene and protein expression. The best example of how donor and cloned offspring can dramatically diverge is illustrated by Copy-Cat (the cloned felid offspring) and Rainbow (the female DNA donor) [140] . Even though Rainbow cat had a classic tortoiseshell coat color pattern (patches of red and black), this pattern was not reproduced in Copy-Cat, who instead displayed a mixture of white to tabby coat color. In cats, a tortoiseshell coat color pattern results from selective X inactivation within different regions of the skin, with X Orange active in the red or orange coat color regions resulting in deposition of pheomelanin within the hair follicles. Disruptions in the MC1R can result in a shift in melanization of the hair follicle from eumelanin to pheomelanin [141, 142] . In tortoiseshell cats, the product of the X Orange allele might competitively antagonize or interrupt the function of the MC1R, with orange coat color patches resulting in the regions that express this allele. In contrast, the WT black allele permits the formation of eumelanin in regions where the second X chromosome is active. The orange locus has been mapped on the feline X chromosome near the centromeric region (Xcen) [143] . As with other X-chromosome-linked genes, inactivation of the X Orange locus is regulated by complex epigenetic mechanisms, including inactive X-specific transcripts (Xist) RNA, histone methylation changes, and DNA hypermethylation [144] . The tabby coat observed in the cloned kitten, by contrast, is not patterned by X inactivation and X-linked alleles. Rather, the Tabby locus maps to feline autosomal chromosome B1 [145] . The most likely explanation for the difference in coat patterning between the cloned kitten and her genetic twin is that the cloning procedure led to a delayed or otherwise unexpected program of X inactivation, which resulted in the Tabby locus controlling the coat color markings. Unfortunately, the study did not compare the methylation patterns or examine for other epigenetic changes between the two cats. A second study has compared the methylation patterns in somatic and placental cells of cloned and noncloned cats. Cloned felids display hypermethylation of placental genes, but no methylation differences in other organs were noted between cloned and noncloned cats [146] . Based on these studies, it can be concluded that cloned cats demonstrate alterations in methylation patterns compared with those derived through sexual reproduction, but these methylation changes may not be ubiquitous in all organs. Methylation abnormalities have been described in newborn cloned mice [147] . One potential mechanism driving this aberrant methylation is the promiscuous expression of the somatic form of DNMT1s in cloned preimplantational murine embryos [148] . Deviant methylation patterns in the brain, placenta, and preimplantational embryos, and histone acetylation patterns in preimplantational embryos have been reported in larger cloned animals, including swamp buffalo [149] and cattle [150, 151] . The placenta and brain of cloned bovine fetuses display hypermethylation of the leptin (Lep) and POU ANIMAL MODELS TO STUDY EPIGENETICS domain, class 5, transcription factor 1 (Pou5f1) genes compared with artifically inseminated (AI) control-derived animals, where these genes are instead hypomethylated in the corresponding organs [151] .
Other studies in cloned bovine embryos suggest that most SNCTs fail because of hypermethylation changes in the cloned preimplantational embryos [152, 153] , which might suggest genome-wide failure of reprogramming. Treatment of donor cells with 5-aza-2
0 -deoxycytidine has been tested to determine whether such a strategy increases SCNT efficiency and decreases the degree of methylation of the resulting cloned embryos [152] . However, the results of these studies are mixed. The drug suppresses the increased methylation patterns of DNA otherwise observed in cloned embryos. However, high doses of this compound, correspondingly, decrease the efficiency of SCNT, which is presumably due to pernicious effects on the donor cells. In contrast to the bovine and murine studies, cloned preimplantational rabbit embryos do not demonstrate any differences in methylation patterns compared with in vitro-fertilized embryos [154] .
These combined studies suggest that DNA methylation patterns within cloned embryos could be gene specific, vary with the conditions employed for the SCNT, and display species-specific variability. Because divergent DNA methylation results have been observed across species, it may not be possible either to draw any general conclusions or to choose a universal animal model that illustrates a relationship between cloning, genome reprogramming, and DNA methylation particularly well. Rather, we need to consider the underlying epigenetic mechanisms operating in each animal species derived by SCNT. For instance, is DNMT1 more active or genomic DNA more susceptible to methylation in cloned bovine and murine embryos than in rabbit embryos? Such studies might reveal that reprogramming is subject to marked species variability in both naturally fertilized and SCNTderived embryos. Based on these results, SCNT and IVF techniques might be improved by tailoring media supplements to achieve optimal conditions for reprogramming to occur in each species. For instance, although the preliminary SCNT studies that used bovine cells treated with 5-aza-2 0 -deoxycytidine produced mixed effects [152] , other compounds that modulate epigenetic modifications, such as hmC [73] , might be considered to prevent the abnormal hypermethylation changes observed in SCNT-derived bovine embryos.
CONCLUDING REMARKS
The field of epigenetics has garnered considerable interest in this decade. The U.S. National Institutes of Health and its Center Directors placed epigenetics as one of the major Roadmap initiatives for immediate implementation in 2007. One reason for this high priority is that epigenetics probably accounts for phenotypic patterns and diseases that elude conventional genetics and are governed by environmental factors, including diet. Moreover, therapeutic intervention might be more readily designed to target underlying epigenetic alterations, such as modifying the methylation status of candidate genes, rather than disease-causing mutations. A vy and Axin1 Fu mice provide valuable animal models to determine how epigenetic factors, such as diet, might lead to disease. Additionally, animal models hold the key to understanding the long-term transgenerational epigenetic effects that environmental alterations can impose. Many of these animal results might be extrapolated to humans, and thus their judicious interpretation is essential to guide clinicians' advice to their patients. Such research is also relevant to decisions made by governments in attempts to decide whether or not to limit exposure of humans and animals to certain manmade chemicals and even to natural components, such as phytoestrogens, in the environment, not just because these compounds could have an adverse effect on the health of those exposed, but also because they could influence the health of their children and grandchildren.
Although these animal models have extended our knowledge of the epigenetic mechanisms, particularly DNA methylation changes, associated with various diseases, including ones that are inherited, several questions still remain to be addressed. One such question is whether additional pathologies linked to diet and environment can be correlated with epigenetic changes other than DNA methylation and whether good animal models for their study will emerge. Another question is whether methyl supplementation of adult diets might be useful in averting cancer or ameliorating conditions, such as the obesity observed in A vy mice. It is also important to note (Tables 1-3 ) that the majority of mouse models currently used for epigenetics research involve inbred strains presenting identical alleles at each locus. Accordingly, the observations made on such mice may not be valid for humans or, for that matter, most outbred species. As whole epigenomic studies are done in a wide range of species, we might identify outbred strains of mice with similar epigenetic marks that govern a range of diseases, and these epigenetic foci are susceptible to components in the maternal and possibly adult diet. If such outbred strains are discovered, however, any confounding genetic variation needs to be addressed. To provide a framework for any animal model used for environmental epigenetic studies, some guidelines for consideration are detailed in Table 4 .
Although considerable progress has been made in the field of epigenetics since Waddington, our understanding of the subject and its role in disease continues to evolve. Interdisciplinary collaborations that link a range of disciplines, including reproductive biology, neurobiology, pathology, and molecular biology, to list but a few, will be needed to tackle the complex questions that will likely arise as new animal models are discovered and exploited to determine how environment affects normal development and disease through the epigenome. Guidelines for animal models used for environmental epigenetic studies.
1. The animal should possesses a gene sequence whose expression provides observable phenotypic outcomes, e.g. a visible marker, such as coat color, or behavioral abnormalities, that easily distinguish the affected animals from ''wild-type'' animals without the modification and lacking the associated phenotype. 2. Read out from this sequence needs to be governed by defined epigenetic change(s), such as DNA methylation. The sequence should not be highly polymorphic as a result of genetic changes, such as single nucleotide polymorphisms (SNP), point, and frame-shift mutations, which would complicate the phenotypic analysis. 3. The epigenetically controlled sequence should be exquisitely sensitive to environmental factors, such as maternal or adult diet, toxicants, or endocrine disruptors. 4. The epigenetically-influenced locus should behave similarly in other species in response to the environmental ''insult,'' thereby providing possible insights into a human or animal health concern. 5. Ideally, the animal model would be outbred, thereby more closely mirroring the genetic diversity of human populations.
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